These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 494489)

  • 1. Commentary; re FDA reissues proposal for evaluating assays for carcinogenic compounds.
    Jones LD
    Vet Hum Toxicol; 1979 Aug; 21(4):296-7. PubMed ID: 494489
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA reissues proposal for evaluating assays for carcinogenic compounds.
    Vet Hum Toxicol; 1979 Jun; 21(3):208-9. PubMed ID: 462744
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary antioxidants and cancer.
    Milner JA
    Bol Asoc Med P R; 1986 Jun; 78(6):261-3. PubMed ID: 3463314
    [No Abstract]   [Full Text] [Related]  

  • 5. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The carcinogenic and anticarcinogenic properties of neozon D].
    Pliss GB; Vlasov NN; Zabezhinskiĭ MA
    Vopr Onkol; 1991; 37(1):60-4. PubMed ID: 2014680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Conference on Harmonisation: guidance on testing for carcinogenicity of pharmaceuticals. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Feb; 63(35):8983-6. PubMed ID: 12269370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated daily intakes of butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and tert-butyl hydroquinone (TBHQ) antioxidants in Korea.
    Suh HJ; Chung MS; Cho YH; Kim JW; Kim DH; Han KW; Kim CJ
    Food Addit Contam; 2005 Dec; 22(12):1176-88. PubMed ID: 16356880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the problem of permissible doses of substances presenting carcinogenic hazards].
    Neĭman IM
    Vopr Pitan; 1967; 26(3):3-7. PubMed ID: 5611456
    [No Abstract]   [Full Text] [Related]  

  • 10. A case study of statistics in the regulatory process: the FD&C Red No. 40 experiments.
    Lagakos S; Mosteller F
    J Natl Cancer Inst; 1981 Jan; 66(1):197-212. PubMed ID: 6935460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Potential hazard of tissue culture assays arising from carcinogenic compounds incompletely removed by washing.
    Sansone EB; Poiley JA; Pienta RJ; Lebherz WB
    Cancer Res; 1976 Jul; 36(7 PT 1):2455-8. PubMed ID: 1277152
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of 'secondary mechanism' in the regulation of carcinogens; a chronology.
    Scheuplein RJ
    Cancer Lett; 1995 Jun; 93(1):103-12. PubMed ID: 7600537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of certain food additives and contaminants. Forty-first report of the Joint FAO/WHO Expert Committee on Food Additives.
    World Health Organ Tech Rep Ser; 1993; 837():1-53. PubMed ID: 8266711
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of toxicity or carcinogenicity of S-170, a sucrose fatty acid ester, in F344 rats.
    Yoshida M; Katsuda S; Nakae D; Maekawa A
    Food Chem Toxicol; 2004 Apr; 42(4):667-76. PubMed ID: 15019192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carcinogenicity studies in experimental animals. I. Design and performance].
    Feron VJ; de Vrijer F; van der Heijden CA
    Ned Tijdschr Geneeskd; 1986 Jun; 130(23):1049-51. PubMed ID: 3724897
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating substances for promotion, cofactor effects and synergy in the carcinogenic process.
    Weinstein IB
    J Environ Pathol Toxicol; 1980 Mar; 3(4 Spec No):89-101. PubMed ID: 7391739
    [No Abstract]   [Full Text] [Related]  

  • 18. Design of cancer assays for pharmaceutical agents.
    Meyers DB; Young SS; Gries CL
    J Natl Cancer Inst; 1985 May; 74(5):1151-2. PubMed ID: 3858583
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemical carcinogens: screening, testing, risk assessment for man.
    Schramm T; Teichmann B
    Neoplasma; 1981; 28(2):129-31. PubMed ID: 7254431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antioxidants to minimize the human health risk associated to mutagenic/carcinogenic heterocyclic amines in food.
    Vitaglione P; Fogliano V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 802(1):189-99. PubMed ID: 15036011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.